Skip to main content

TIGR® Matrix Surgical Mesh and hernia study results presented at the 7th International Congress of the Asia Pacific Hernia Society 2011.

Press Release   •   Nov 08, 2011 12:01 GMT

To mark this occasion, Professor Stellan Björk, Principal Investigator and Consultant Surgeon at Sahlgrenska University Hospital, Gothenburg, Sweden, will lecture on "Results of the first-in-man trial of a new synthetic long-term resorbable surgical mesh" in the main scientific session. (http://www.aphs2011.org/schedule.php)

APHS 2011 marks an important milestone for TIGR® Matrix and Novus Scientific as we are able to finally meet the demand from Asian surgeons for a synthetic long-term resorbable mesh. Our plan is to expand registration of TIGR® Matrix  to a number of key markets in Asia, so we can offer TIGR® Matrix  to leading surgeons and hospitals across Asia”, said Thomas Engström, CEO & President of Novus Scientific.

“A number of renowned surgeons in Asia are already involved in a multicenter randomized controlled study using TIGR® Matrix . We are excited to be able to provide TIGR® Matrix  for their regular clinical practice soon”, said Tac-Whei Ong, VP Sales and Marketing, Asia Pacific.

TIGR® Matrix  is the World’s 1st Long-Term Resorbable Synthetic Mesh. US FDA cleared TIGR® Matrix  Surgical Mesh for use in reinforcement of soft tissues where weakness exists in January 2010. It received CE Mark approval in August 2011.

TIGR® Matrix  Surgical Mesh is available for sale in the U.S. and selected European countries.

 

CONTACT:  
Tac-Whei Ong: +66-817 33 9524- tacwhei.ong@novusscientific.com

 

About Novus Scientific

Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable (100% absorbable) synthetic medical devices.  Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden.   The company’s roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The US Division, Novus Scientific, Inc. is headquartered near Boston, one of the world’s foremost medical research cities. From this hub, Novus Scientific, Inc. will distribute TIGR® Matrix Surgical Mesh throughout the United States.

TIGR® Matrix - The world’s 1st long-term resorbable, 100% absorbable synthetic mesh with unique patented dual-fiber construction, designed for gradually increasing mechanical compliance.

TIGR® is a registered trademark of Novus Scientific Pte. Ltd